No consensus exists for use of anticoagulation for calf vein thrombosis

Michael J Anstadt1, T Calloway Robertson, Ross Milner

  • 1Department of Surgery, Loyola University Medical Center.

Vascular
|March 23, 2013
PubMed

Insights

Treatment for calf vein thrombosis (CVT) lacks consensus. Practices vary widely, with nearly half of physicians not using anticoagulation and a notable use of IVC filters for CVT management.

Area of Science:

  • Vascular Medicine
  • Thrombosis Research
  • Medical Practice Patterns

Background:

  • Calf vein thrombosis (CVT) treatment guidelines are not well-defined.
  • Current clinical practice for CVT management shows significant variability.
  • Understanding physician approaches to CVT is crucial for developing standardized protocols.

Purpose of the Study:

  • To assess current practice patterns in managing calf vein thrombosis (CVT) at a single institution.
  • To identify physician preferences regarding anticoagulation, treatment duration, and use of inferior vena cava (IVC) filters for CVT.

Main Methods:

  • An online survey with 8 multiple-choice questions was distributed to physicians.
  • The survey focused on the management strategies for calf vein thrombosis.
  • Ninety-nine physicians from various specialties participated in the survey.

Main Results:

  • Nearly half of physicians (48.5%) anticoagulate patients with CVT, while 51.5% do not.
  • Among those using anticoagulation, low molecular weight heparin was preferred (62.3%).
  • Treatment durations varied, with 58% opting for 3 months and 30% for 6 months.
  • Of physicians not anticoagulating, 71.2% used duplex exams to monitor clot progression.
  • Inferior vena cava (IVC) filters were used in 46% of cases with anticoagulation contraindications and 13.7% for clot propagation.

Conclusions:

  • There is a significant lack of consensus in the treatment of calf vein thrombosis (CVT).
  • The utilization rate of IVC filters for CVT appears higher than anticipated.
  • Further research is needed to establish evidence-based guidelines for CVT management.

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Varicose Veins II: Diagnostic Studies and Interprofessional Care01:26

Varicose Veins II: Diagnostic Studies and Interprofessional Care

Varicose veins, or varicosities, develop when the valves in the veins, which control blood flow, weaken or damage. It causes blood to pool and the veins to enlarge. Understanding the clinical manifestations, diagnostic approaches, and management options for varicose veins is crucial for effective treatment and relief.Clinical manifestationsClinical manifestations of varicose veins include a heavy, achy feeling or pain after prolonged standing or sitting. This discomfort can often be relieved by...